THuNDRous news for human dopamine researchers: A selective dopamine D1 receptor antagonist will soon be available for clinical research

Abstract

Get full access to this article

View all access options for this article.

References

Andersen

Gronvald

Hohlweg

et al . (1992) NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists. Eur J Pharmacol 219: 45–52.

Skrumsager

Christensen

Snel

et al . (1995) Tolerability, safety and pharmacokinetics of single dose and multiple dosing of the selective D1 antagonist NNC 01-0687 in healthy subjects. Psychopharmacology 121: 294–299.

Sugamori

Hamadanizadeh

Scheideler

et al . (1998) Functional differentiation of multiple dopamine D1-like receptors by NNC 01-0012. J Neurochem 71: 1685–1693.

Tice

Hashemi

Taylor

et al . (1994) Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes. Pharmacol Biochem Behav 49: 567–571.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.32 MB

0.30 MB